INTERVIEWS

Dr. Angela Stoehr, OB/GYN, addresses how the pandemic exacerbated the opioid epidemic and the need to refocus on non-opioid pain management approaches after surgery across several procedures especially in women’s health. 

Dr. Sham Dholakia, MD, Chief Medical Officer at CareDx, a company focused on high-value healthcare solutions for transplant patients, discusses the Assessing Chimerism and Relapse of Bone marrow/HCT transplant using AlloHeme Testing (ACROBAT) study at the Cleveland Clinic in Ohio. 

Amir Mansouri, PhD, CEO and Co-Founder of SprintRay, discusses how his vision to revolutionize the dental industry with new “on-demand” 3D printing technology, which will be released in early 2022, inspired him and his company to address dental access inequality globally. In fact, SprintRay will soon announce an exciting partnership to launch a charitable initiative to provide underserved global populations with high-quality dental care. 

Dr. Samuel Kim, a thoracic surgeon at Northwestern Medicine discusses the Ambulatory Precision Lung Sparing (A-PLUS) surgery program born from the need to be able to screen and treat patients for lung cancer during the pandemic. The doctors at Northwestern Medicine spent the past several years honing this highly precise, minimally invasive, lung-conserving, robot-guided outpatient surgery where the patient can be released the same day. 

Dr. Campbell Rogers, Executive Vice President and Chief Medical Officer at HeartFlow discusses some of the latest developments in cardiovascular care, including HeartFlow’s technology, which leverages artificial intelligence to create a personalized 3D model of a patient’s heart to help physicians diagnose heart disease, the leading cause of death in the world. 

Dr. Brian Koffman, Executive Vice President and Chief Medical Officer, CLL (chronic lymphocytic leukemia) Society and a CLL patient discusses the impact and burden of COVID on immunocompromised patients, who may not be able to mount the proper immune response to build antibodies needed to fight against the virus. He also talks about need for preventative options beyond vaccines.

Returning guest, Dr. Larry Edwards, Professor of Medicine, Division of Rheumatology and Clinical Immunology, and Program Director and Vice Chairman of the Department of Medicine at the University of Florida in Gainesville discusses a presentation from the American College of Rheumatology (ACR) Convergence 2021 Virtual Annual Meeting titled “Gout Stigma: Investigating the existence of gout stigma and its impact on patient perceptions and treatment decisions” (Abstract 0680) 

Dr. Waqaas Al-Siddiq, founder and CEO of Biotricity, is a young entrepreneur who founded Biotricity after working in technology and finance and has a background in computer engineering. Today, he discusses their suite of devices and software for real time remote cardiac monitoring and cardiac-oriented telehealth. Bioflux ® is Biotricity’s core product which is a comprehensive mobile cardiac telemetry (MCT) solution encompassing a device, software, and 24/7 monitoring that integrates seamlessly into cardiologists’ existing systems. This allows physicians to see more patients, perform more procedures, and identify which patients need more time and attention. 

Dr. Alison Darcy, President and Founder of Woebot Health discusses key findings of their survey “A Paradigm Shift: Consumer Attitudes Toward Mental Health Technology in 2021” She talks about the state of mental health in America and the future of mental health technology. 

Dr. Lloyd Miller, MD, PhD, Vice President, Immunodermatology Disease Area Leader at Janssen, discusses new data presented at the 2021 European Academy of Dermatology Venereology Congress (EADV) showing TREMFYA provided durable complete and almost complete skin clearance responses and was well-tolerated with low risk of infection and low rates of anti-drug antibodies in psoriasis (PsO) through up to five years. The patient population studied included PsO patients who switched to TREMFYA from adalimumab. Lloyd talks about what these results mean for patients and healthcare providers.